Pharmaceutical Statistics Using SAS
by Ph. D. Alex Dmitrienko, Ph. D. Christy Chuang-Stein, Sr. Ralph B. D'Agostino
References
Chuang-Stein, C. (2004)."Seize the opportunities." Pharmaceutical Statistics. 3, 157–159.
DiMasi, J., Hansen, R.W., Grabowski, H.G. (2003). "The price of innovation: new estimates of drug development costs." Journal of Health Economics. 22, 151–185.
"FDA 'Critical Path' May Lead To Changes In Dosing, Active-Control Trials." December 13, 2004. Pink Sheet. 31.
Grieve, A. (2002). "Do statisticians count? A personal view."Pharmaceutical Statistics. 1, 35–43.
International Conference of Harmonization of Pharmaceuticals for Human Use (ICH) E9. (1998). "Statistical Principles for Clinical Trials." Available at http://www.ich.org.
Lendrem, D. (2002). "Statistical support to non-clinical."Pharmaceutical Statistics. 1, 71–73. Pharmaceutical ...
Become an O’Reilly member and get unlimited access to this title plus top books and audiobooks from O’Reilly and nearly 200 top publishers, thousands of courses curated by job role, 150+ live events each month,
and much more.
Read now
Unlock full access